Compare SIGI & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SIGI | MMSI |
|---|---|---|
| Founded | 1926 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.9B |
| IPO Year | N/A | 1996 |
| Metric | SIGI | MMSI |
|---|---|---|
| Price | $82.63 | $81.85 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 9 |
| Target Price | $84.40 | ★ $105.89 |
| AVG Volume (30 Days) | ★ 572.8K | 527.6K |
| Earning Date | 01-01-0001 | 03-24-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | N/A | ★ 25.31 |
| EPS | N/A | ★ 1.49 |
| Revenue | N/A | ★ $1,356,514,000.00 |
| Revenue This Year | $5.00 | $13.67 |
| Revenue Next Year | $4.87 | $6.16 |
| P/E Ratio | ★ $11.38 | $54.71 |
| Revenue Growth | N/A | ★ 7.89 |
| 52 Week Low | $71.75 | $77.62 |
| 52 Week High | $93.38 | $107.27 |
| Indicator | SIGI | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 49.65 |
| Support Level | $81.60 | $79.51 |
| Resistance Level | $85.84 | $85.09 |
| Average True Range (ATR) | 2.04 | 2.13 |
| MACD | -0.64 | 0.32 |
| Stochastic Oscillator | 11.56 | 83.55 |
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, and Investments. Majority of revenue is gained from Standard Commercial Lines segment, which comprises of property and casualty insurance products and services provided in the standard marketplace to commercial enterprises, which are typically businesses, non-profit organizations, and local government agencies.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.